Skip to main content
Medical information Clinical review pending

Genetic Testing

Peripheral Blood for Karyotyping Couple

Karyotyping for couples planning a family. This test examines chromosomes in peripheral blood samples to identify potential genetic abnormalities that could affect offspring. A doctor's prescription is required.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Peripheral blood samples from both partners.
Results
10-12 days. Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. No special preparation is typically required, but follow any specific instructions provided by the laboratory or your doctor.
Test priceKSh 15,200

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Peripheral Blood for Karyotyping Couple test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Couples planning pregnancy
  • ✓Family history of genetic disorders
  • ✓Recurrent miscarriages
  • ✓Advanced maternal age (over 35)
  • ✓Known carriers of genetic conditions
02

In plain language

What this test helps you understand

Identifies chromosomal abnormalities in couples planning pregnancy, assessing the risk of passing genetic conditions to offspring.
The Peripheral Blood for Karyotyping Couple test is a diagnostic tool used to examine the chromosomes in peripheral blood samples from both partners. This test is particularly important for couples planning to conceive, as it can identify chromosomal abnormalities that may impact future children. Karyotyping allows us to visualize the number and structure of chromosomes, providing insights into genetic conditions and reproductive health.

This test detects chromosomal abnormalities, such as deletions, duplications, or translocations, which could lead to genetic disorders. By analyzing the chromosomes of both partners, healthcare professionals can assess the genetic health relevant to family planning.

Couples who may benefit from this test include those with a family history of genetic disorders, those experiencing recurrent miscarriages, individuals over the age of 35 planning pregnancy, or couples known to be carriers of genetic conditions.

Taking this test offers several benefits, including the early identification of potential genetic issues, support for informed family planning decisions, guidance for further testing or interventions if needed, and peace of mind for couples preparing for parenthood.

Results are typically available within 10-12 days. A healthcare professional will interpret the findings and discuss their implications for reproductive health.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. No special preparation is typically required, but follow any specific instructions provided by the laboratory or your doctor.
SamplePeripheral blood samples from both partners.
MethodologyKaryotyping (chromosome analysis) performed on cultured peripheral blood cells.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects numerical and structural chromosomal abnormalities but may not identify all genetic conditions. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Karyotyping is a laboratory procedure that analyzes the number and structure of chromosomes in a cell sample.
This test helps identify chromosomal abnormalities in both partners that could potentially affect the health of future children.
Yes, a doctor's prescription is required for this test.
Results are typically available within 10-12 days. Confirm with the laboratory before booking.
The test detects chromosomal abnormalities like deletions, duplications, or translocations.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp